Europe's Choice
Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Statements & press releases 20.01.26
EFPIA Statement on the EU–Mercosur Free Trade Agreement
While the agreement includes some progress for the innovative pharmaceutical sector, particularly through partial tariff reductions, it could have gone further in...
Read Article -
Statements & press releases 20.01.26
EFPIA statement following European Parliament plenary vote on the Critical Medicines Act
EFPIA acknowledges today’s vote in the European Parliament plenary on the Critical Medicines Act (CMA).
Read Article -
Blog articles 20.01.26
From readiness to reality: preparing Europe for the next phase of Alzheimer’s care (Guest blog)
Europe has reached a turning point on Alzheimer’s disease, where scientific breakthroughs are no longer theoretical, but demand urgent action to turn innovation...
Read Article -
External Event 02.03.26
Health Economics and Policy Evaluation Course March 2026
Join the Health Economics and Policy Evaluation ONLINE Course 2026, delivered by the University of Oxford.
View Event -
External Event 10.03.26
2nd European Summit for Women Leaders in Life Sciences
Get ready for C5’s 2nd Annual European Summit for Women Leaders in Life Sciences Law — two days of impactful discussions, diverse perspectives, and meaningful...
View Event -
External Event 24.03.26
DIA Europe 2026
Join the DIA Europe 2026 in March to explore how Europe can bring and keep innovation into the system to deliver better outcomes for patients.
View Event